Service by

Home Journal Issues Instructions for Authors Editorial Board About Journal Aims & Scope


Original Research Open Access
RMJ. 2010; 35(2): 165-167


Use of Injection Solcoseryl for the treatment of oligohydramnios

Khurshid Shabbir Raja, Huma Tasleem.

Abstract
Objectives
To assess the efficacy of drug hemodialysate (solcoseryl) on liquor volume in intrauterine growth restricted (IUGR) babies and their outcome in view of APGAR score and their health status.
Patients and Methods
In this study, a total of 70 patients with IUGR were included and it was carried out at Shifa International Hospital and Shifa Foundation Community Health Clinic Islamabad from January 2006 to December 2008. The patients were divided in two groups with 35 in each group. In group one, no infusion of solcoseryl was given, only left lateral position and plenty of fluids were advised (Conventional therapy). In group two, 10 mg of solcoseryl was given in 500 ml of normal saline at the rate of 125 ml/hour per day after 28 weeks of gestation (Interventional therapy). If the patient was hypertensive, 500 ml of Dextrose water was used instead of normal saline. Minimum one dose and maximum 28 doses were used. Both groups were compared with level of amniotic fluid index before and after the treatment.
Results
Out of 70 patients, frequency of IUGR in group one it was 6.832.24, (t = -3.28, 95% CI, -2.89 -.704),
Conclusion
Solcoseryl is the drug of choice in pregnant women with IUGR, especially after twenty eight week of gestation.

Key words: Solcoseryl, oligohyramnios, IUGR.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
Print this article Print this Article
How to cite this articleHow to cite this article
Export to
Export to
Related Records
 Articles by Khurshid Shabbir Raja
Articles by Huma Tasleem
on Google
on Google Scholar
Article Statistics
 Viewed: 15040
Downloaded: 813
Cited: 0


How to Cite this Article
Pubmed Style

Raja KS, Tasleem H. Use of Injection Solcoseryl for the treatment of oligohydramnios. RMJ. 2010; 35(2): 165-167.



Web Style

Raja KS, Tasleem H. Use of Injection Solcoseryl for the treatment of oligohydramnios. www.scopemed.org/?mno=3788 [Access: July 27, 2017].



AMA (American Medical Association) Style

Raja KS, Tasleem H. Use of Injection Solcoseryl for the treatment of oligohydramnios. RMJ. 2010; 35(2): 165-167.



Vancouver/ICMJE Style

Raja KS, Tasleem H. Use of Injection Solcoseryl for the treatment of oligohydramnios. RMJ. (2010), [cited July 27, 2017]; 35(2): 165-167.



Harvard Style

Raja, K. S. & Tasleem, H. (2010) Use of Injection Solcoseryl for the treatment of oligohydramnios. RMJ, 35 (2), 165-167.



Turabian Style

Raja, Khurshid Shabbir, and Huma Tasleem. 2010. Use of Injection Solcoseryl for the treatment of oligohydramnios. Rawal Medical Journal, 35 (2), 165-167.



Chicago Style

Raja, Khurshid Shabbir, and Huma Tasleem. "Use of Injection Solcoseryl for the treatment of oligohydramnios." Rawal Medical Journal 35 (2010), 165-167.



MLA (The Modern Language Association) Style

Raja, Khurshid Shabbir, and Huma Tasleem. "Use of Injection Solcoseryl for the treatment of oligohydramnios." Rawal Medical Journal 35.2 (2010), 165-167. Print.



APA (American Psychological Association) Style

Raja, K. S. & Tasleem, H. (2010) Use of Injection Solcoseryl for the treatment of oligohydramnios. Rawal Medical Journal, 35 (2), 165-167.




Instructions for Authors

AUTHOR LOGIN

REVIEWER LOGIN

Indexed In

WHO Index Medicus IMEMR,
Emromedex,
Pakmedinet,
ExtraMED and
Scopus

Approved by the Higher Education Commission of Pakistan and Pakistan Medical and Dental Council



The articles in Rawal Medical Journal are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.